Prof D. Chen-Yi Lee from the Department of Electronics Engineering at National Chiao Tung University in Taiwan, provides fascinating details about the project Toward Mobile Health-Care with Medical-IoT Devices.
Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
John H. Breen, political scientist and advisor, explains the humanitarian necessity of a multilateral response to COVID-19 and offers policy suggestions.
Machine learning has already been widely accepted in the private sector, however, it is often feared in the public sector. Here, Simon Dennis, Director of AI & Analytics Innovation, SAS UK, explores the benefits of using machine learning in healthcare.
Stopping smoking is one of the most effective ways to protect your health from COVID-19, but there is a lack of digital resources available to help smokers quit during the coronavirus crisis. Alan Sutherland, CEO of Kind Consumer Ltd, shares his thoughts here.
Jim Darragh, CEO of Totalmobile, explores how rapidly deployable technologies are ready and available to help tackle the challenges faced by field-based public sector workers during the fight against COVID-19.
Clare Vale, Managing Director of Sign Solutions, discusses how COVID-19 has highlighted the need for better access to health services for the Deaf community.
Mike Odling-Smee, Technical Director at Aire Logic, takes us on a journey around interoperability in the NHS beyond the cliché when it comes to the opportunities around healthcare.
Jen-Yuan (James) Chang, Distinguished Professor at the Department of Power Mechanical Engineering, National Tsing Hua University, Taiwan, lifts the lid on human motion capture through a novel wearable multi-linkage sensory system.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.